跳至主要内容
临床试验/NCT04525768
NCT04525768Unknown不适用

Characteristic of Patients With Gastroesophageal Varices and Portal Cavernoma

Shanghai Zhongshan Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2020年10月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
80
试验地点
1
主要终点
History of variceal bleeding

研究概览

简要总结

Myeloproliferative neoplasms (MPNs), including polycythemia vera, essential thrombocythemia, and primary myelofibrosis, may lead to gastroesophageal varices. The quality of life, morbidity, and mortality of MPN patients mainly depend on disease-related symptoms, thromboembolic and hemorrhagic complications. Previous studies have shown that JAK2 V617F has a prominent role in vascular risk and MPN-associated gastroesophageal varices. Portal vein thrombosis and portal cavernoma frequently occur in the MPN population and the management of gastroesophageal varices in these patients are sometimes technically difficult. The aim of this study is to investigate the the characteristics of patients with gastroesophageal varices and portal caver cavernoma with or without JAK2 mutation.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • male or female patients aged 18-75
  • diagnosed as portal hypertension and portal cavernoma by contrast-enhanced computed tomography
  • underwent JAK2 mutation test

排除标准

  • combined known etiologies of chronic liver disease, including hepatitis, primary biliary cirrhosis, schistosomiasis, and non-alcoholic fatty liver disease.
  • other factors judged by the investigator that may affect the safety of the subject or the compliance of the trial. Such as serious illnesses (including mental illness) that require combined treatment, serious laboratory abnormalities, or other family or social factors.

结局指标

主要结局

History of variceal bleeding

时间窗: 1 day (the same time as diagnosis)

Have a history of the occurrence of gastroesophageal variceal bleeding

次要结局

  • 1-year death rate(1 year)
  • Complications of portal hypertension(1 year)

研究者

发起方
Shanghai Zhongshan Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

XiaoquanHUANG

Resident

Shanghai Zhongshan Hospital

研究点 (1)

Loading locations...

相似试验